Golgi defects enhance APP amyloidogenic processing in Alzheimer's disease

E-ISSN： 1521-1878|37|3|240-247

ISSN： 0265-9247

Source： BIOESSAYS (ELECTRONIC), Vol.37, Iss.3, 2015-03, pp. : 240-247

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti-amyloidogenic therapies: strategies for prevention and treatment of Alzheimer’s disease

By Hamaguchi T. Ono K. Yamada M.

Cellular and Molecular Life Sciences CMLS, Vol. 63, Iss. 13, 2006-07 ,pp. : 1538-1552

Springer Publishing Company

Access to resources Recommend Favorite

Monogenetic determinants of Alzheimer's disease: APP mutations

By Goate A. M.

Cellular and Molecular Life Sciences CMLS, Vol. 54, Iss. 9, 1998-09 ,pp. : 897-901

Springer Publishing Company

Access to resources Recommend Favorite

PS Dependent APP Cleavage Regulates Glucosylceramide Synthase and is Affected in Alzheimer's Disease

Cellular Physiology and Biochemistry, Vol. 34, Iss. 1, 2014-06 ,pp. : 92-110

Karger

Access to resources Recommend Favorite

The physical approximation of APP and BACE‐1: A key event in alzheimer's disease pathogenesis

DEVELOPMENTAL NEUROBIOLOGY, Vol. 78, Iss. 3, 2018-03 ,pp. : 340-347

John Wiley & Sons Inc

Access to resources Recommend Favorite

Tocotrienol Affects Oxidative Stress, Cholesterol Homeostasis and the Amyloidogenic Pathway in Neuroblastoma Cells: Consequences for Alzheimer’s Disease

By Grimm Marcus O. W. Regner Liesa Mett Janine Stahlmann Christoph P. Schorr Pascal Nelke Christopher Streidenberger Olga Stoetzel Hannah Winkler Jakob Zaidan Shatha R. Thiel Andrea Endres Kristina Grimm Heike S. Volmer Dietrich A. Hartmann Tobias

International Journal of Molecular Sciences, Vol. 17, Iss. 11, 2016-10 ,pp. : 1809-1809

MDPI

Access to resources Recommend Favorite